Medicine and Dentistry
Congestive Heart Failure
100%
Hazard Ratio
26%
Cardiovascular Disease
26%
Cohort Analysis
22%
Heart Left Ventricle Ejection Fraction
21%
Atrial Fibrillation
20%
Percutaneous Coronary Intervention
19%
Cardiovascular System
17%
Coronary Artery Disease
16%
Brain Natriuretic Peptide
15%
Pulmonary Hypertension
13%
Prevalence
13%
Ejection Fraction
12%
Blood Pressure
12%
Heart Failure with Preserved Ejection Fraction
12%
Heart Failure with Reduced Ejection Fraction
12%
Chronic Thromboembolic Pulmonary Hypertension
11%
Hemodynamic
10%
Acute Decompensated Heart Failure
10%
Sex Difference
9%
Angioplasty
9%
Diseases
9%
Systolic Blood Pressure
9%
Malignant Neoplasm
8%
Stenosis
8%
Heart Disease
8%
Echocardiography
8%
Incision
8%
Intima-Media Thickness
7%
Urinary System
7%
Pulmonary Artery
7%
Proportional Hazards Model
7%
Diabetes
6%
Major Bleeding
6%
Heart Muscle Ischemia
6%
Observational Study
6%
Genetic Risk
6%
Antithrombotic Therapy
5%
Randomized Controlled Trial
5%
COVID-19
5%
Lower Digestive Tract
5%
Lung
5%
Body Mass Index
5%
Combination Therapy
5%
Apoplexy
5%
Atherosclerosis
5%
Odds Ratio
5%
Ischemic Heart Disease
5%
Lung Artery Pressure
5%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
86%
Prevalence
17%
Coronary Artery Disease
14%
Atrial Fibrillation
14%
Brain Natriuretic Peptide
13%
Chronic Thromboembolic Pulmonary Hypertension
13%
Cardiovascular Disease
13%
Diseases
12%
Cohort Study
11%
Acute Heart Failure
10%
Heart Failure with Preserved Ejection Fraction
10%
Heart Infarction
9%
Heart Failure with Reduced Ejection Fraction
9%
Heart Muscle Ischemia
8%
Combination Therapy
7%
Kampo Medicine (Drug)
7%
Pulmonary Hypertension
7%
Angiotensin Receptor Antagonist
7%
Cerebrovascular Accident
7%
Observational Study
6%
Bleeding
6%
Syndrome
6%
Olmesartan
6%
Isotopes of Potassium
5%
Randomized Controlled Trial
5%
Comorbidity
5%